References
- Holzgreve W, Holzgreve B, Curry CJR. Nonimmune hydrops fetalis: diagnosis and management. Semin Perinatol 1985; 9: 52–67.
- Iskaros J, Jauniaux E, Rodeck C. Outcome of non-immune hydrops fetalis diagnosed during the first half of pregnancy. Obstet Gynecol 1997; 90: 321–5.
- Jauniaux E. Diagnosis and management of early non-immune hydrops fetalis. Prenat Diagn 1997; 17: 1261–8.
- Ayida GA, Soothill PW, Rodeck CH. Survival in non-immune hydrops fetalis without malformation or chromosomal abnormalities after invasive treatment. Fetal Diagn Ther 1995; 10: 101–5.
- Weiner CP. Umbilical pressure measurement in the evaluation of nonimmune hydrops fetalis. Am J Obstet Gynecol 1993; 168: 817–23.
- McCoy MC, Katz VL, Gould N, Kuller JA. Non-immune hydrops after 20 weeks of gestation: review of 10 years’ experience with suggestions for management. Obstet Gynecol 1995; 85: 578–82.
- Boyd PA, Keeling JW. Fetal hydrops. J Med Genet 1992; 29: 91–7.
- Schulman LP, Emerson DS, Grevengood C, Felker RE, Gross SJ, Philips OP et al. Clinical course and outcome of fetuses with isolated cystic nuchal lesions and normal karyotypes detected in the first trimester. Am J Obstet Gynecol 1994; 171: 1278–81.
- Cadkin A, Pergament E. Bilateral pleural effusion at 8.5 weeks’ gestation with Down syndrome and Turner syndrome. Prenat Diagn 1993; 13: 659–60.
- Lam YH, Ghosh A, Tang MHY, Lee CP, Sin SY. Early ultrasound prediction of pregnancies affected by homozygous α-thalassemia-1. Prenat Diagn 1997; 17: 327–32.
- Taipale P, Hiilesmaa V Salonen R, Ylöstalo P. Increased nuchal translucency as a marker for fetal chromosomal defects. N Engl J Med 1997; 337: 1654–8.
- Machim GA. Hydrops revisited: literature review of 1414 cases published in the 1980s. Am J Med Genet 1989; 34: 366–90.